基他胺在慢性疼痛缓解中的有效性和安全性的性别和年龄差异
Gisèle Pickering1,2, Marion Voute1, Marc Sorel3
1University Hospital Clermont-Ferrand, Inserm CIC 1405, Platform of Clinical Investigation, Platform of Clinical Investigation, F-63000 Clermont-Ferrand, France.
Journal of clinical medicine
|June 26, 2025
概括
对男性和女性来说,重复的胺治疗显示出类似的疼痛和抑郁缓解. 然而,女性经历了更多的不良事件,单次胺剂可能在男性中更有效.
科学领域:
- 神经科学是一个神经科学.
- 药理学 药理学是指药理学的学科.
- 疼痛医学 医学 疼痛医学
背景情况:
- 在全球范围内,治疗慢性疼痛和抑郁症的胺使用量正在上升.
- 有限的研究存在于基因基因基因基因基因基因基因基因因基因基因基因基因基因基因基因基因基因基因基因基因基因基因基因基因基因基因基因基因基因基因基因基因基因基因基因基因基因基因基因基因基因基因基因基因基因基因基因基因基因基因基因基因基因基因基因基因基因基因基因基因基因基因基因基因基因基因基因基因基因基因基因基因基因基因基因基因基因基因基因基因基因基因基因基因基因基因基因基因基因基因基因基因基因基因基因基因基因基因基因基因基因基因基因基因基因基因基因基因基因基因基因基因基因基因
- 这项研究解决了了解胺治疗结果中性别差异的差距.
研究的目的:
- 调查基胺治疗慢性疼痛的疗效和安全性的潜在性别和年龄差异.
- 分析单次和重复的胺胺管理对患者结果的影响.
主要方法:
- 这是一项长达一年的前性多中心观察性研究,涉及585名慢性疼痛患者.
- 患者接受了一次或两次或多次胺剂的管理.
- 结果包括疼痛强度,抑郁,焦虑,生活质量,不良事件和剂量.
主要成果:
- 在重复使用的凯胺治疗疼痛,焦虑或抑郁症的有效性方面,没有发现显著的性别或年龄差异.
- 与男性相比,女性报告的不良事件发生率更高 (19%对13%).
- 单次服用胺对男性的疗效可能比女性更大,尤其是年轻男性.
结论:
- 重复服用胺表明,在治疗疼痛,焦虑和抑郁症方面,无论性别和年龄,都具有一致的疗效.
- 对不良事件的监测至关重要,特别是在女性患者中.
- 进一步的研究可能会根据性别明确单剂量胺的最佳使用.
相关概念视频
Analgesia and Pain Management
822
Pain is critical to various clinical pathologies, provoking an urgent need for effective management. Pain, whether acute or chronic, is a complex neurochemical process. Its alleviation depends on the type, with nonopioid analgesics effective for mild to moderate pain, such as musculoskeletal or inflammatory pain, while neuropathic pain responds best to anticonvulsants, tricyclic antidepressants, or serotonin/norepinephrine reuptake inhibitors. For severe acute or chronic pain, opioids may be...
822
Parenteral Anesthetics: Overview
211
Intravenous anesthetics are drugs administered parenterally to induce anesthesia or sedation. Propofol is a widely used agent formulated as a 1% emulsion in soybean oil, glycerol, and egg phosphatide. It induces rapid anesthesia primarily due to its rapid distribution from the bloodstream to target tissues and is metabolized in the liver. However, it can cause significant pain on injection and hypertriglyceridemia. Fospropofol, a water-based prodrug of propofol, lacks these adverse effects.
211
Opioid Analgesics: Synthetic and Semisynthetic Opioids
453
Synthetic and semisynthetic opioids are pivotal in pain management and tackling opioid addiction. Semisynthetic opioids, including morphinans (morphine derivatives), oxycodone, oxymorphone, hydrocodone, and hydromorphone, have improved pharmacokinetic profiles compared to morphine. Additionally, heroin and 6-MAM (6-Monoacetylmorphine) show better CNS penetration than morphine due to heightened lipid solubility. Hydromorphone, a potent opioid, undergoes hepatic metabolism to form the active...
453
Skeletal Muscle Relaxants: Adverse Effects
485
Skeletal muscle relaxants are widely used for muscle paralysis and relieving pain following any muscle injury or stiffness. However, depending on the drug type, they can have adverse effects that range from mild to severe. Usually, nondepolarizing neuromuscular blockers have minimal side effects. For example, drugs like d-tubocurarine, cisatracurium, and rocuronium cause hypotension, whereas drugs like baclofen, when stopped abruptly, can lead to the recurrence of spastic conditions.
Unlike...
Unlike...
485
Sedatives and Hypnotics Drugs: Miscellaneous Agents
248
Sedatives and hypnotics encompass a wide range of substances, each with its unique mechanism of action, uses, and potential adverse effects.
Melatonin congeners like ramelteon (Rozerem) and tasimelteon (Hetlioz) selectively bind to melatonin receptors (MT1 and MT2) and thus mimic the actions of melatonin, a hormone that regulates sleep-wake cycles. Tasimelteon is primarily used for non-24-hour sleep-wake disorder, common in blind patients. They are also used to treat conditions like insomnia...
Melatonin congeners like ramelteon (Rozerem) and tasimelteon (Hetlioz) selectively bind to melatonin receptors (MT1 and MT2) and thus mimic the actions of melatonin, a hormone that regulates sleep-wake cycles. Tasimelteon is primarily used for non-24-hour sleep-wake disorder, common in blind patients. They are also used to treat conditions like insomnia...
248


